Clinical Trials
11 trialsNCT05208047 2026-05-22
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc.
Phase 3 Active not recruiting
NCT04557449 2025-10-01
CDK4i
Pfizer
Phase 2 Active not recruiting
NCT06407518 2025-04-06
POMPPR
Sixth Affiliated Hospital, Sun Yat-sen University
Phase NA Recruiting
NCT06111872 2025-03-25
Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.
National University of Malaysia
Phase 2 Completed
NCT04908176 2024-12-13
A Drug-drug Interaction Study of Avapritinib and Midazolam
Blueprint Medicines Corporation
Phase 1 Completed
NCT01488045 2023-05-23
Compare Propofol to Fentanyl and Midazolam for Colonoscopy
Trinity Health Michigan
Phase NA Completed
NCT02857270 2022-11-22
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Eli Lilly and Company
Phase 1 Completed
NCT02937506 2017-12-26
Patient Satisfaction With Propofol for Out Patient Colonoscopy
Mount Carmel Health System
Phase 4 Completed
NCT02504164 2016-03-07
Effect of Midazolam Premedication on the Satisfaction Levels of Patients After Endoscopic Submucosal Dissection
Yonsei University
Phase NA Completed
NCT01402089 2016-02-02
Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients
Cantonal Hospital of St. Gallen
Phase 4 Completed
NCT02027311 2015-06-29
Etomidate vs. Midazolam for Sedation During ERCP
Cheju Halla General Hospital
Phase 4 Completed